42.07
-1.44 (-3.30%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Devices (US) | Mixed | Bearish |
| Medical Devices (Global) | Mixed | Bearish | |
| Stock | Tandem Diabetes Care, Inc. | Bearish | Bullish |
Stockmoo Score
|
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days. |
|
| Sector | Healthcare |
| Industry | Medical Devices |
| Investment Style | Small Core |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 58.00 (Oppenheimer, 37.88%) | Buy |
| Median | 55.00 (30.75%) | |
| Low | 39.00 (Baird, -7.29%) | Hold |
| Average | 50.80 (20.77%) | |
| Total | 3 Buy, 2 Hold | |
| Avg. Price @ Call | 42.24 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Morgan Stanley | 22 Aug 2024 | 45.00 (6.98%) | Hold | 42.49 |
| Canaccord Genuity | 08 Aug 2024 | 57.00 (35.50%) | Buy | 36.88 |
| Baird | 02 Aug 2024 | 39.00 (-7.29%) | Hold | 41.67 |
| Piper Sandler | 02 Aug 2024 | 55.00 (30.75%) | Buy | 41.67 |
| Oppenheimer | 10 Jun 2024 | 58.00 (37.88%) | Buy | 48.50 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |